EDAP to Participate in the UBS Global Healthcare Conference

EDAP (Nasdaq: EDAP) will participate in the UBS Global Healthcare Conference held November 10-13, 2025 in Palm Beach Gardens, Florida.

Rhea-AI Summary

EDAP (Nasdaq: EDAP) will participate in the UBS Global Healthcare Conference held November 10-13, 2025 in Palm Beach Gardens, Florida. CEO Ryan Rhodes and CFO Ken Mobeck are scheduled to host one-on-one investor meetings on Monday, November 10, 2025 at PGA National Resort Hotel.

Meetings are 1x1 investor sessions; registration is via UBS for clients or through a UBS sales representative.

Argus Oct 27 session

-1.77% close to close Open Argus

Details

News Market Reaction – EDAP

On Oct 27, the day this news came out, EDAP closed 1.77% below the previous close.

Data tracked by StockTitan Argus for the Oct 27 session.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

 EDAP to Participate in the UBS Global Healthcare Conference

Company to Host 1x1 Investor Meetings on Monday, November 10^th, 2025

AUSTIN, Texas, October 27, 2025 -- EDAP TMS SA (Nasdaq: EDAP) (“the Company”), the global leader in robotic energy-based therapies, today announced that Ryan Rhodes, Chief Executive Officer, and Ken Mobeck, Chief Financial Officer, are scheduled to host 1x1 investor meetings at the upcoming UBS Global Healthcare Conference, which is being held November 10-13, 2025, in Palm Beach Gardens, Florida.

Date:                    Monday, November 10^th

Format:               1x1 investor meetings

Location:               PGA National Resort Hotel, Palm Beach Gardens, Florida

Registration:         Click here to register for the conference (for UBS clients only), or please contact your UBS sales representative.         

        

About EDAP TMS SA

A recognized leader in robotic energy-based therapies, EDAP TMS develops, manufactures, promotes and distributes worldwide minimally invasive medical devices for various conditions using ultrasound technology. By combining the latest technologies in imaging, robotics and precise non-invasive energy delivery, EDAP introduced the Focal One® in Europe and in the U.S. as the leading prostate focal therapy controlled by urologists with the potential to expand to multiple indications beyond prostate cancer. For more information on the Company, please visit https://focalone.com/.

Company Contact
Blandine Confort
Investor Relations / Legal Affairs
EDAP TMS SA
+33 4 72 15 31 50
bconfort@edap-tms.com

Investor Contact
John Fraunces
LifeSci Advisors, LLC
(917) 355-2395
jfraunces@lifesciadvisors.com

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

When will EDAP (Nasdaq: EDAP) hold investor meetings at the UBS Global Healthcare Conference in 2025?

EDAP will host 1x1 investor meetings on Monday, November 10, 2025.

Who from EDAP will attend the UBS Global Healthcare Conference on November 10, 2025?

CEO Ryan Rhodes and CFO Ken Mobeck are scheduled to attend and host investor meetings.

Where are EDAP's investor meetings at the UBS Global Healthcare Conference taking place?

Meetings will occur at PGA National Resort Hotel, Palm Beach Gardens, Florida during the conference.

How can investors register for EDAP meetings at the UBS Global Healthcare Conference November 2025?

Registration is available through UBS for clients or by contacting your UBS sales representative.

What format will EDAP use for investor interactions at the UBS Global Healthcare Conference?

EDAP will conduct one-on-one (1x1) investor meetings on the scheduled date.

What are the dates of the UBS Global Healthcare Conference where EDAP is participating?

The conference runs November 10-13, 2025, with EDAP meetings on November 10.